You are here: Industry Insights > Cancer

News List

Is cancer fundraising fuelling deceit? europeanpharmaceuticalreview
September 18, 2018
Researchers questioned whether cancer crowdfunding elicits deception, especially when offering patients treatments with no scientific backing…
No Apparent Short-Term Cancer Risk From Recalled Valsartan drugs
September 14, 2018
Users of valsartan contaminated with N-nitrosodimethylamine (NDMA) seem not to have increased cancer risk, according to a study published online Sept. 12 in The BMJ.
At Least 15 Men Near Ground Zero Have Breast Cancer drugs
September 13, 2018
At least 15 men who worked near Ground Zero after the 9/11 attacks have been diagnosed with breast cancer, a New York City law firm claims.
Chi-Med’s fruquintinib gets approval for colorectal cancer in China pharmaceutical-technology
September 11, 2018
Hutchison China MediTech (Chi-Med) has secured approval from the National Medical Products Administration of China (NMPA) for the use of fruquintinib capsules to treat metastatic colorectal cancer (CRC).
Blood tester Guardant Health files for Nasdaq IPO fiercebiotech
September 10, 2018
Guardant also plans to submit its test for international regulatory approvals, to help boost its coverage and reimbursements.
Agios, Celgene terminate partnership for developing cancer treatment biospectrum
September 10, 2018
Agios Pharmaceuticals and Celgene have mutually agreed to terminate their collaboration and license agreement inked on April 27, 2015, to develop and commercialize products containing pan-IDH inhibitor AG-881.
Cross-Industry Collaboration Announced to Treat Metastatic Colorectal Cancer americanpharmaceuticalreview
September 07, 2018
GNS Healthcare announced a cross-industry partnership with Amgen and the Alliance for Clinical Trials in Oncology (Alliance) that will apply causal artificial intelligence (AI) and simulation to combined clinical trial data to identify ...
SpringWorks names a CEO, inks a combo therapy deal with BeiGene fiercebiotech
September 07, 2018
SpringWorks came to life with a clutch of drugs licensed from Pfizer, but won't rely on Pfizer’s shelves forever, with plans to boost its pipeline by partnering with other biopharmas and academic institutions.
New cancer treatment uses enzymes to boost immune system and fight back worldpharmanews
August 29, 2018
Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.
GIC receives govt funding for immuno-oncology project biospectrumasia
August 23, 2018
The company is currently conducting studies on a family of compounds targeted towards the Adenosine 2a receptor.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page